title: A place for ipratropium bromide in the treatment of severe acute asthma.
abstract: Twenty-four consecutive patients admitted to hospital with severe acute asthma were studied. Eleven were given 10 mg salbutamol by nebulizer followed 2 hours later by 500 micrograms of nebulized ipratropium bromide. These patients had a greater response in PEFR than 13 patients given two doses of 10 mg salbutamol 2 hours apart.
authors.forename: M J
authors.initials: MJ
authors.lastname: Ward
authors.forename: J T
authors.initials: JT
authors.lastname: Macfarlane
authors.forename: D
authors.initials: D
authors.lastname: Davies
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000420:Albuterol / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D001286:Atropine Derivatives / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D009241:Ipratropium / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
chemical_list: D001286:Atropine Derivatives; D009241:Ipratropium; D000420:Albuterol